UthPeak® NMNH Million Dollars Subsidy Program

Overview

UthPeak-R-NMNH-Million-Dollars-Subsidy-Program.png

Introducing the UthPeak® Million Dollar Campaign! Unlock the full marketing potential of the groundbreaking reduced NMN, NMNH. With our extensive support, we’re here to elevate your brand to unparalleled success.

We understand the vital role marketing plays in your growth, which is why we offer up to a 30% subsidy on your marketing expenses. This financial boost eases the costs associated with NMNH, allowing you to invest more in showcasing UthPeak® NMNH and enjoy increased sales and financial support.

Ready to seize the opportunity? Download now to discover more about UthPeak® NMNH!

This content is paid by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now

Related Topics

IngredientsHealth

Latest Content

Related Resources

The Only & 1st NMN Got Novel Food EFSA Positive Safety Opinion

The Only & 1st NMN Got Novel Food EFSA Positive Safety Opinion

Paid for by Effepharm Ltd

White Paper

On 11th May 2026, EFSA officially published a positive scientific opinion on EffePharm’s β-NMN as a novel food. This is the first-ever EU official safety endorsement for NMN. UTHEVER® is the 1st NMN ingredient brand to receive EFSA’s positive opinion.

Uthever® NMN: Novel Food Approval Nearing Final Stage

Uthever® NMN: Novel Food Approval Nearing Final Stage

Paid for by Effepharm Ltd

White Paper

One Step Away from EU Market Compliance for NMN. The official positive opinion of Novel Food is expected to be published shortly, which means Uthever® NMN will be the first compliant ingredient.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.